Patient P-01414
Therapy response
Favorable
Tolerance
Improving
GI state
Improving
Inflammatory state
Improving
Nutritional resilience
Favorable
Discontinuation risk
12%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 NBL-101 started — Baseline state S13
What changed?
Trajectory is tracking the baseline prediction.
Primary contributors, last 14 days
- Toxicity-7
- GI instability-6
- Inflammatory activity-6
- Nutritional resilience+3
- Treatment adherence-3
What helped?
No interventions yet.
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients.
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Autonomic recovery ↓20
- Wearable3,877 steps/day
DNA
Fictional pharmacogenomic panel
- CYP2D6 Intermediate metabolizerExpected exposure
- MTHFR C677TReduced folate turnover
Microbiome
Shannon diversity 4.6 · butyrate capacity 82/100
- Akkermansia muciniphilaNormal
- Faecalibacterium prausnitziiNormal
- Bacteroides fragilisNormal
- Bifidobacterium longumNormal
- EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 66 ms
- Sleep
- 7.7 h
- Steps
- 4,965
- Resting HR
- 73 bpm
Daily log: GI score 20, nutritional resilience 66, adherence 89.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Keep fibre steady; no new sources this week
- Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
- Log the daily check-in; one line is enough
- A 15-minute walk after lunch
- Keep the sleep window steady
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the scheduled dose as agreed with your care team
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.
| Patient | Similarity | Baseline | Intervention | Outcome | Response today |
|---|---|---|---|---|---|
| P-01766 | 38% | S05 | AD-05 | no change | 90 |
| P-01804 | 26% | S19 | AD-05 | improved | 61 |
| P-01541 | 25% | S09 | AD-05 | no change | 43 |
| P-01377 | 24% | S11 | AD-05 | no change | 42 |
| P-01329 | 43% | S08 | BR-03 | improved | 79 |
| P-01677 | 40% | S05 | BR-03 | no change | 86 |
| P-01495 | 34% | S07 | BR-03 | improved | 85 |
| P-01689 | 26% | S13 | BR-03 | no change | 50 |
| P-01654 | 38% | S08 | CR-01 | improved | 85 |
| P-01430 | 25% | S05 | CR-01 | improved | 54 |
| P-01479 | 36% | S15 | DT-01 | improved | 84 |
| P-01855 | 32% | S04 | DT-01 | improved | 73 |